Belete Teferedegne, DVM, PhD, DABT

Director
AstraZeneca
Gaithersburg, Maryland, United States

Presentation(s):

• Advances and Challenges in Oligonucleotide and mRNA Therapeutics: New Strategies and Regulatory Perspectives (S12)

  Tuesday, November 19, 2024
  2:00 PM - 5:00 PM CT

• Nonclinical Safety Assessments of the Next Generation of mRNA Vaccines for SARS-CoV-2 and Other Respiratory Viruses (S12-3)

  Tuesday, November 19, 2024
  2:40 PM - 3:15 PM CT